| Autor: |
Ismaila AS; Value Evidence and Outcomes, R&D Global Medical, GSK, 1250 South Collegeville Road, Collegeville, PA, USA. afisi.s.ismaila@gsk.com.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. afisi.s.ismaila@gsk.com., Rothnie KJ; Value Evidence and Outcomes, R&D Global Medical, GSK, London, UK., Wood RP; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK., Banks VL; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.; Integrated Evidence Generation (Women's Health Care), Bayer PLC, Reading, UK., Camidge LJ; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK., Czira A; Value Evidence and Outcomes, R&D Global Medical, GSK, London, UK., Compton C; Global Medical, GSK, London, UK., Sharma R; Global Medical, GSK, London, UK., Millard SN; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK.; P1vital Limited, Wallingford, Oxfordshire, UK., Massey O; Real-World Evidence, Adelphi Real World, Bollington, Cheshire, UK., Halpin DMG; College of Medicine and Health, University of Exeter Medical School, University of Exeter, Exeter, UK. |
